Arnab Guha: New Insights into miRNA Therapies for Endometriosis and Depression
Arnab Guha, Founder, Director and Chief Visionary Officer at Impeccable Innovations Pvt. Ltd., shared a post on LinkedIn:
“Endometriosis induces depression in mouse models via miRNA dysregulation, leading to hippocampal shrinkage and reduced neurogenesis.
Targeting specific miRNAs – such as inhibitors for miR-125b and miR-451a, or a let-7b mimic – lowers depressive behaviors in tail suspension tests and restores hippocampal area, alongside upregulated genes like GAD45B, JUNB, ARC, and PROX1.
The findings build on prior research linking miRNAs like let-7b to endometriosis treatment in mice, suggesting potential miRNA-based therapies for alleviating psychological symptoms in affected patients.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Feb 17, 2026, 13:28Dinesh Velu Rajan: Exploring the Role of Dysbiosis in ART Outcomes
-
Feb 17, 2026, 13:19Dinesh Velu Rajan: Revolutionizing Male Infertility Diagnosis with Epigenetic Tools
-
Feb 17, 2026, 13:17Insights into Antiphospholipid Syndrome from Experts – American College of Rheumatology
-
Feb 17, 2026, 13:15Jecko Thachil: Unraveling Russell’s Viper Venom in Antiphospholipid Syndrome
-
Feb 17, 2026, 13:12Rohini Chavare: PGT Technology Enhancements Driving IVF Success Rates
-
Feb 17, 2026, 13:10Gharam Mohammad: Uterine Factors for Personalized IVF Strategies
-
Feb 17, 2026, 13:07Ashok Yadav: Chronic Chorioamnionitis with Eosinophils
-
Feb 17, 2026, 12:48Plastic Pollution in Human Reproduction: Should We Worry? – RBMO
-
Feb 17, 2026, 12:39Applications Open for ESHRE Nurses and Midwives Certification 2026 – ESHRE